RPRX Earnings

Quarterly EPS
$1.22
Q3 2024
$0.47
Q4 2024
$0.55
Q1 2025
$0.08
Q2 2025
$0.67
Q3 2025
$0.50
Q4 2025
$0.67
Q1 2026
$0.04
Q2 2026
Latest Revenue674.1M
Latest Net Income81.5M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$0.04674.1M81.5M+16.5%-50.0%
Q1 2026$0.67630.6M468.3M+11.0%+21.8%
Q4 2025$0.50622.0M355.9M+4.8%+6.4%
Q3 2025$0.67609.3M444.2M+7.9%-45.1%
Q2 2025$0.08578.7M92.6M+7.7%-65.2%
Q1 2025$0.55568.2M434.4M+0.0%+5,400.0%
Q4 2024$0.47593.6M334.4M-0.4%-57.7%
Q3 2024$1.22564.7M806.4M+5.3%+662.5%
Q2 2024$0.23537.3M194.4M
Q1 2024$0.01568.0M-4273000
Q4 2023$1.11596.1M717.6M
Q3 2023$0.16536.3M122.1M
Royalty Pharma (RPRX) — Earnings